Acepodia Secures $100 Million Series D Financing to Advance

First-In-Class Cell Therapies with Antibody-Cell Conjugation (ACC) Platform Series D led by Digital Mobile Venture with participation from additional existing investors Funds will support expansion and progress of oncology pipeline, including ACE1831... Biopharmaceuticals, Oncology, Venture Capital Acepodia, Antibody-Cell Conjugation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news